VISTIN PHARMA ASA (VISTN.OL) Stock Price, Forecast & Analysis
Europe - Euronext Oslo - OSL:VISTN - NO0010734122 - Common Stock
VISTN.OL Key Statistics, Chart & Performance
The current stock price of VISTN.OL is 21 NOK. In the past month the price increased by 6.6%. In the past year, price decreased by -10.26%.
VISTN.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SAN.PA | SANOFI | 10.92 | 201.67B | ||
| SNW.DE | SANOFI | 10.88 | 200.78B | ||
| 1SAN.MI | SANOFI | 10.69 | 197.40B | ||
| MRK.DE | MERCK KGAA | 14.97 | 55.52B | ||
| UCB.BR | UCB SA | 40.34 | 50.38B | ||
| UNC.DE | UCB SA | 39.36 | 49.15B | ||
| BAYN.DE | BAYER AG-REG | 7.24 | 38.00B | ||
| 1BAYN.MI | BAYER AG-REG | 7.12 | 37.38B | ||
| IPN.PA | IPSEN | 12.18 | 10.48B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.74 | 10.19B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 110.1 | 10.19B | ||
| 1JAZZ.MI | JAZZ PHARMACEUTICALS PLC | 21.08 | 8.94B |
Related stock screener links
About VISTN.OL
Company Profile
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.
Company Info
VISTIN PHARMA ASA
Ostensjoveien 27
Oslo OSLO NO
Employees: 73
Phone: 4748926506
VISTIN PHARMA ASA / VISTN.OL FAQ
What does VISTN do?
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.
What is the current price of VISTN stock?
The current stock price of VISTN.OL is 21 NOK.
What is the dividend status of VISTIN PHARMA ASA?
VISTIN PHARMA ASA (VISTN.OL) has a dividend yield of 6.01%. The yearly dividend amount is currently 0.
How is the ChartMill rating for VISTIN PHARMA ASA?
VISTN.OL has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the market capitalization of VISTN stock?
VISTIN PHARMA ASA (VISTN.OL) has a market capitalization of 931.14M NOK. This makes VISTN.OL a Small Cap stock.
VISTN.OL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to VISTN.OL. When comparing the yearly performance of all stocks, VISTN.OL is a bad performer in the overall market: 84.22% of all stocks are doing better.
VISTN.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to VISTN.OL. While VISTN.OL has a great health rating, its profitability is only average at the moment.
VISTN.OL Financial Highlights
Over the last trailing twelve months VISTN.OL reported a non-GAAP Earnings per Share(EPS) of 1.72. The EPS increased by 11.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.84% | ||
| ROA | 18.05% | ||
| ROE | 25.86% | ||
| Debt/Equity | 0.14 |